您的位置: 首页 > 农业专利 > 详情页

ADMINISTERING INHIBITORS OF TGFBETA SIGNALING IN COMBINATION WITH BENZOTHIAZEPINE DERIVATIVES TO IMPROVE MUSCLE FUNCTION IN CANCER PATIENTS
专利权人:
Indiana University School of Medicine;The Trustees of Columbia University in the City of New York
发明人:
Andrew R. Marks,Theresa A. Guise
申请号:
US13844321
公开号:
US20140128349A1
申请日:
2013.03.15
申请国别(地区):
US
年份:
2014
代理人:
摘要:
Methods and compositions useful for the treatment and/or prevention of muscle weakness in cancer patients. In certain embodiments, the methods of the present invention include administering to a cancer patient a therapeutically or prophylactically effective amount of one or more inhibitors of TGFbeta signaling in combination with one or more benzothiazepine derivatives.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充